October 30, 2017

PolyOne Declares Quarterly Dividend Increase of 30%, Announces Three-Year Dividend Increase Plan

January 30, 2020 Jan. 30, 2020 has also granted the underwriters an option, exercisable for 30 days after the date of the final prospectus supplement, to purchase up to an additional 2,000,000 common shares at the public offering price less an underwriting discount.

The charts above compare 30% short glass-fiber filled samples and show a noticeable difference in the moisture uptake behavior of PK versus to PA6 & PA66. The image below demonstrates the outcome against 30% sulfuric acid. 30% H₂SO₄, 24 HRs, 23°C

S A F E T Y F I R S T PolyOne Corporation 7 Injuries per 100 Workers Spartech Acquisition 1.3 1.1 1.1 0.85 0.65 0.57 0.54 0.97 0.84 0.74 0.74 0.69 0.51 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 G R E A T P L A C E T O W O R K PolyOne Corporation 8 * Pro Forma for sale of DSS Operating Income % of Sales 2006 Q3 YTD 2019 Color, Additives & Inks 1.7% 15.5% Specialty Engineered Materials 1.1% 11.8% Distribution 2.6% 6.3% 2009 2010 2011 2012 2013 2014 2015 2016* 2017* 2018 $2.43 P R O O F O F P E R F O R M A N C E C O N S E C U T I V E Y E A R S PolyOne Corporation 9 1 0 $0.13 $0.68 $0.82 $1.00 $1.31 $1.80 $1.96 $2.06 $2.21 A D J U S T E D E P S E X P A N S I O N 2018 2019E $1.65 $1.51 Pro Forma for sale of PP&S T R A N S F O R M A T I O N H E A D L I N E S PolyOne Corporation 10 C O M M O D I T Y T O S P E C I A L T Y T R A N S F O R M A T I O N PolyOne Corporation 11 • Volume driven, commodity production • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures • Shift to value-based selling & an innovative culture • New leadership team appointed • Implementation of four pillar strategy • Investment in commercial training and innovation • Faster growing, high margin focus • Accelerated growth with world class vitality index • Significant commercial resource additions • Expanded margins with specialty focus • Acquired strategic, bolt-on companies to expand technology offerings and improve geographic breadth Volume Value Transformation The Future 2006 - 2013 2013 – 20192000-2005 2006 - 2013 • Landmark portfolio transformation creates specialty growth company • Sustainability / mega- trends drive above market growth 2020 and Beyond F I T W I T H F O U R P I L L A R S T R A T E G Y PolyOne Corporation 12 Specialization • Innovation-led organization with heavy emphasis on R&D • World-class expertise in color formulation • Strong presence in specialty end markets including Consumer, Packaging and Healthcare Globalization • Diverse geographic portfolio with an established presence in every major region • Expands PolyOne’s ability to serve customers in key growth areas including India, China and Southeast Asia Operational Excellence • Extensive manufacturing footprint with 46 facilities • Organizational focus on optimizing supply chain to better serve customers • Color design expertise Commercial Excellence • Value-focused salesforce with vast experience marketing and commercializing specialty technologies • Diverse customer portfolio with established OEM’s People Experienced and talented associates with a winning mentality L E V E R A G I N G G L O B A L M E G A T R E N D S 13 Facilitate alternative energy solutions Light- weighting Reduce packaging materials Improve recyclability Reduce spread of infection T R A N S P O R T A T I O N P A C K A G I N G H E A L T H C A R EC O N S U M E R PolyOne Corporation E N D M A R K E T T R A N S F O R M A T I O N PolyOne Corporation 14 Building & Construction 5% 2006 2019E PF* 4% 12% 10% 18% 8% 20% 2006 2019E PF* Healthcare Consumer Packaging 50% 22% High Growth End Markets Percentage of Total Revenue 38% * 2019E Pro Forma for PP&S Divestiture and Clariant Color & Additive Masterbatch business E N D M A R K E T T R A N S F O R M A T I O N PolyOne Corporation 15 Packaging 8% Building & Construction 38% Wire & Cable 11% Industrial 10% Electrical & Electronic 7% 2006 2019E PF* Healthcare 4% Transportation 12% Consumer 18% Building & Construction 5% Wire & Cable 6% Industrial 12% Electrical & Electronic 5% Appliance 3% Textiles 6% Transportation 13% Healthcare 12% Packaging 20% Consumer 10% * 2019E Pro Forma for PP&S Divestiture and Clariant Color & Additive Masterbatch business C O M P L E M E N T A R Y G E O G R A P H I C P R E S E N C E PolyOne Corporation 16 United States 38% Europe 33% Asia 19% Canada 4% Latin America 6% United States 22% Europe 40% Asia & Middle East 31% Canada 1% Latin America 6% Color & Engineered Materials Clariant Color & Additive Masterbatch Business Net Sales by Geographic Region United States 31% Europe 36% Asia & Middle East 24% Canada 3% Latin America 6% Pro Forma Color & Engineered Materials 531 710 1,042 130 164 208 504 663 880 2014 2018 2019E PF* R&D / Technical Marketing Sales PolyOne Corporation 17 + 34% + 26% + 32% E X P A N S I O N O F C O M M E R C I A L R E S O U R C E S D R I V I N G G R O W T H $2.9 $2.9 $3.5 2015 2016 2017 2018 2019E PF Total + 9% Organic + 5% Revenue in Billions Total + 10% Organic + 7%+ 47% + 27% + 33% $4.0 $3.2 2019E PF* * 2019E Pro Forma for PP&S Divestiture and Clariant Color & Additive Masterbatch business P R I O R A C Q U I S I T I O N S : P R O O F O F P E R F O R M A N C E PolyOne Corporation 18 Commercial Resources Operating Income ($ in millions) Operating Margins 243 340 At Acquisition 2018 $36 $96 At Acquisition 2018 11% 20% At Acquisition 2018 Established Acquisitions (> 7 years) + 40% + 165% + 900 bps U N I F I E D F O C U S O N S U S T A I N A B I L I T Y PolyOne Corporation 19 2006 - 2013 2013 – 2019 PEOPLE PRODUCTS PLANET PERFORMANCE PolyOne Clariant Color & Additive Masterbatch Business • Building mini-recycling plants to facilitate customer projects on design for recycling - CycleWorks • Uses packaging additives & colorants to improve recyclability and enhance automated sorting • Manufactures oxygen scavengers to extend shelf-life of perishable items and reduce material requirements • Combines UV-blocking additive colorants & other barriers to prevent spoilage and waste • Offers spin-dyeing solutions that use significantly less water than traditional methods, allowing for sustainable coloration of textiles • Produces infrared absorbing additives that reduce energy requirements for bottle manufacturing ($ in millions) PolyOne (Continuing Operations) Clariant Color & Additive Masterbatch Business Synergies New PolyOne 2019E Total Sales $2,860 $1,150 $4,010 2019E Adjusted EBITDA $310 $130 $60 $500 % Margin 10.8% 11.3% 12.5% 2019E CapEx $60 $85 % Sales 2.1% 2.1% 2019E Free Cash Flow $170 $250 2019E Adjusted EPS $1.65 $2.22 2019E PF Adjusted EPS $1.65 $2.50 P O L Y O N E + C L A R I A N T C O L O R & A D D I T I V E M A S T E R B A T C H B U S I N E S S PolyOne Corporation 20 (1) Excludes step-up of depreciation & amortization related to purchase accounting of transaction (1) $0.85/share O V E R 8 5 % O F A D J U S T E D E B I T D A F R O M S P E C I A L T Y PolyOne Corporation 21 46% 66% 0% 20% 40% 60% 80% 100% 2005 2010 2015 2019E PF % o f A d ju s t e d E B IT D A * JV's Performance Products & Solutions Distribution Specialty 7% 87% * Adjusted EBITDA is EBITDA excluding corporate costs and special items ** 2019E Pro Forma for PP&S Divestiture and Clariant Color & Additive Masterbatch business acquisition with synergies Specialty EBITDA $14M $117M $273M $500M ** PolyOne Corporation 22 T R A N S A C T I O N O V E R V I E W • Expected mid-2020, subject to regulatory approvals and customary closing conditions Closing Conditions / Timing • Committed financing in place • Permanent financing to be combination of available cash on-hand, new debt and equity component to limit leverage • Equity issuance of $400 to $500MM • Target net leverage below 3.5x, 3.1x synergized, with intention to de-lever below 3.0x within 2 years PolyOne Corporation 23 • $1.45 B net purchase price • Represents 11.1x adjusted EBITDA (excluding synergies), 7.6x adjusted EBITDA (including synergies) • Pre-tax synergies of $60MM expected to be fully realized by the end of 2023 • Synergies realized from sourcing, operational, technology / commercial, and general administrative Transaction Value Synergies Financing Estimated Synergy Breakdown $60MM • Expect EBITDA synergies of $60MM – Proven integration expertise with a decade of acquisition experience – Administrative synergies reflect reduction of duplicative internal and third-party costs • Run rate synergies of $20MM by the end of Year 1 with $60MM achieved by the end of Year 3 • Significant additional opportunity for geographical expansion – Clariant Color & Additive Masterbatch business has complementary regional presence in key growth areas including India & Southeast Asia • Opportunity to accelerate growth with a combined portfolio of innovative solutions aligned with sustainability megatrends Sourcing 40% Operational 30% Administrative 30% PolyOne Corporation 24 S I G N I F I C A N T S Y N E R G Y O P P O R T U N I T I E S C A P I T A L S T R U C T U R E / L E V E R A G E PolyOne Corporation 25 At Close Year 1 Year 2 3.2x 3.5x 3.1x 2.6x Pro Forma with Synergies 2019E PF Two year leverage goal (1) Pro Forma Capitalization is for illustrative purposes only; amounts may vary depending on various market and other factors.

SPORTING GOODS Boots, bindings, protective equipment MARINE Hull reinforcement, seats, paddles 50% Long Glass Fiber Reinforced PP 50% Long Glass Fiber Reinforced PP + 0° CFRTP 50% Long Glass Fiber Reinforced PP + 0°/90° CFRTP 50% Long Glass Fiber Reinforced PP + 0°/90°/90°/0° CFRTP 17K 28K 29K 50% Long Glass Fiber Reinforced PP + 0°/90°/0° CFRTP 29K 31K +60.7% FLEXURAL STRENGTH (ASTM D7264) IMPACT RESISTANCE (ASTM D3763) 50% Long Glass Fiber Reinforced PP 50% Long Glass Fiber Reinforced PP + 0° CFRTP 50% Long Glass Fiber Reinforced PP + 0°/90° CFRTP 50% Long Glass Fiber Reinforced PP + 0°/90°/0° CFRTP 50% Long Glass Fiber Reinforced PP + 0°/90°/90°/0° CFRTP E n e rg y at T o ta l ( J) F o rc e a t P e ak ( kN ) 18 16 14 12 10 8 6 4 2 0 6.0 5.9 4.0 3.0 2.0 1.0 0.0 11.2 15.1 14.6 12.7 16.4 1.2 1.9 2.8 4.0 5.0 +58.3% +34.8% 50% Long Glass Fiber Reinforced PP 50% Long Glass Fiber Reinforced PP + 0° CFRTP 50% Long Glass Fiber Reinforced PP + 0°/90° CFRTP 50% Long Glass Fiber Reinforced PP + 0°/90°/90°/0° CFRTP 17K 28K 29K 50% Long Glass Fiber Reinforced PP + 0°/90°/0° CFRTP 29K 31K +60.7% FLEXURAL STRENGTH (ASTM D7264) IMPACT RESISTANCE (ASTM D3763) 50% Long Glass Fiber Reinforced PP 50% Long Glass Fiber Reinforced PP + 0° CFRTP 50% Long Glass Fiber Reinforced PP + 0°/90° CFRTP 50% Long Glass Fiber Reinforced PP + 0°/90°/0° CFRTP 50% Long Glass Fiber Reinforced PP + 0°/90°/90°/0° CFRTP E n e rg y at T o ta l ( J) F o rc e a t P e ak ( kN ) 18 16 14 12 10 8 6 4 2 0 6.0 5.9 4.0 3.0 2.0 1.0 0.0 11.2 15.1 14.6 12.7 16.4 1.2 1.9 2.8 4.0 5.0 +58.3% +34.8% Application design Modeling & simulation Prototyping & validation Material selection Composite/ resin compatibility Custom formulations Mold filling analysis Technical support Process optimization PROCESSING MATERIALS Material selection is crucial to an application’s success.

PolyOne Corporation Page 4 PolyOne Commodity to Specialty Transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2014 2015 and beyond • Steve Newlin appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • 20 consecutive quarters of double- digit adjusted EPS growth • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Established aggressive 2015 targets • Continue specialty transformation • Goal of $2.50 adjusted EPS by 2015, three times the EPS generated in 2011 of $0.82 • Drive double digit operating income and adjusted EPS growth PolyOne Corporation Page 5 Building & Construction 13% Industrial 12% Transportation 18% Wire & Cable 9% Packaging 16% Consumer 10% HealthCare 11% Appliance 6% Electronics & Electrical 5% 2013 Revenues: $3.8 Billion End Markets 2013 Revenues: $3.8 Billion PolyOne At A Glance United States 67% Europe 14% Canada 7% Asia6% Latin America 6% Specialty 54% PP&S 18% Distribution 28% $13 $31 $46 $46 $92 $96 $122 $195 $0 $50 $100 $150 $200 2006 2007 2008 2009 2010 2011 2012 2013 Specialty Operating Income PolyOne Corporation Page 6 Old PolyOne *Operating Income excludes corporate charges and special items 2% 34% 43% 62% 65% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2013 2014 YTD 2015 % o f O pe ra tin g In co m e* JV's Performance Products & Solutions Distribution Specialty 65-75% Specialty OI $5M $46M $87M $195M $191M Target Mix Shift Highlights Specialty Transformation Transformation 2015 Target PolyOne Corporation Page 7 Confirmation of Our Strategy The World’s Premier Provider of Specialized Polymer Materials, Services and Solutions Specialization Globalization Operational Excellence Commercial Excellence PolyOne Corporation Page 8 Strategy and Execution Drive Results $0.12 $0.27 $0.21 $0.13 $0.68 $0.82 $1.00 $1.31 '06 '07 '08 '09 '10 '11 '12 '13 ‘06-‘13 EPS CAGR = 41% EPS Share Price vs. S&P 500 -150% -50% 50% 150% 250% 350% 450% 550% POL S&P 500 All time high of $43.34 July 1st, 2014 PolyOne Corporation Page 9 2006 2014 YTD 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 14.9% 12 – 16% Global Specialty Engineered Materials 1.1% 12.1% 12 – 16% Designed Structures & Solutions -- 7.6% 8 – 10% Performance Products & Solutions 5.5% 8.1% 9 – 12% Distribution 2.6% 6.2% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 65% 65 – 75% 3) ROIC* 5.0% 10.6% 15% 4) Adjusted EPS Growth N/A 37% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period PolyOne Corporation Page 10 32% Adjusted EPS CAGR from 2011 2015 EPS: $2.50 2011 EPS: $0.82 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental Share Buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid Single Digit Revenue Growth PolyOne Corporation Page 11 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14% 31% 2006 2013 Specialty Platform Gross Margin % 20% 43% 2006 2013 Specialty Vitality Index Target ≥ 35% Vitality Products + 700 to 1000 bps PolyOne Corporation Page 12 Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 4 11 5 10 6 9 3 4 2 15 9 1 10 4 Breakthrough Platform Derivative A Rich Pipeline of Opportunity Number of Projects 25 14 19 17 18 93 Addressable Market ($ millions) TBD TBD $800 $450 $450 $1,700 PolyOne Corporation Page 13 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 14 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of September 30, 2014 Debt Maturities & Pension Funding – 9/30/14 Net Debt / EBITDA* = 1.7x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of September 30, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 9/30/2014 PolyOne Corporation Page 15 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return Expanding our sales, marketing, and technical capabilities Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin Synergy opportunities Adjacent material solutions Repurchased 1.5 million shares in Q3 2014 Repurchased 9.7 million shares since early 2013 10.3 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends  Investing in operational and LSS initiatives (including synergy capture) Manufacturing alignment $0.16 $0.20 $0.24 $0.32 $0.40 $0.10 $0.20 $0.30 $0.40 $0.50 2011 2012 2013 2014 2015 Annual Dividend PolyOne Corporation Page 16 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 17 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne? ��PolyOne Investor Presentation�Goldman Sachs 2014 US Emerging / SMID Cap Growth Conference�New York, NY�November 20, 2014�� Forward-Looking Statements Use of Non-GAAP Measures PolyOne Commodity to Specialty Transformation PolyOne�At A Glance Mix Shift Highlights Specialty Transformation Confirmation of Our Strategy Strategy and Execution Drive Results Proof of Performance & 2015 Goals 32% Adjusted EPS CAGR from 2011 Innovation Drives Earnings Growth A Rich Pipeline of Opportunity Megatrends Aligned with Key End Markets Debt Maturities & Pension Funding – 9/30/14 Free Cash Flow and Strong Balance Sheet �Fund Investment / Shareholder Return PolyOne Core Values Why Invest In PolyOne?

Avient Corporation 1 J E F F E R I E S V I R T U A L I N D U S T R I A L S C O N F E R E N C E A U G U S T 2 0 2 0 Avient Corporation 2 FORWARD LOOKING STATEMENTS • • • • • • • • • • • • • • • • • • • • Avient Corporation 3 U S E O F N O N - G A A P M E A S U R E S • • • Avient Corporation 4 U P D A T E O N T H E C O V I D - 1 9 P A N D E M I C • • • • Avient Corporation 5 2019 Transportation Consumer Discretionary Healthcare Packaging All Other Industries Cost Containment FX 2020 $64.3 18% 18% 9% 6% 16% 2% $46.9 20% • • • • • • S E C O N D Q U A R T E R 2 0 2 0 I N R E V I E W Consumer Discretionary Avient Corporation 6 CLARIANT MASTERBATCH STRATEGIC RATIONALE Avient Corporation 7 F I T W I T H F O U R P I L L A R S T R A T E G Y Specialization • • • Globalization • • Operational Excellence • • • Commercial Excellence • • People Avient Corporation 8 5% 2006 2019E PF* 4% 12% 10% 18% 8% 20% 2006 2019E PF* Healthcare Consumer Packaging 38% * 2019E Pro Forma for PP&S Divestiture and Clariant Masterbatch business Percentage of Total Revenue E N D M A R K E T T R A N S F O R M A T I O N Building & Construction High Growth End Markets 50% 22% Avient Corporation 9 Wire & Cable 11% Industrial 10% Electrical & Electronic 7% Healthcare 4% Packaging 8% Consumer 10% Transportation 12% Building & Construction 38% Healthcare 12% Packaging 20% Consumer 18%Transportation 12% Building & Constrution 5% Wire & Cable 9% Industrial 11% Electrial & Electronic 4% Appliance 2% Textiles 7% 2006 Pro Forma(1) Net Sales by End Market E N D M A R K E T T R A N S F O R M A T I O N Avient Corporation 10 U N I F I E D F O C U S O N S U S T A I N A B I L I T Y 2006 - 2013 2013 – 2019 P E O P L E P R O D U C T S P L A N E T P E R F O R M A N C E •• •• •• Avient Corporation 11 O V E R 8 5 % O F A D J U S T E D E B I T D A F R O M S P E C I A L T Y 46% 66% 0% 20% 40% 60% 80% 100% 2005 2010 2015 Pro Forma % o f A d ju s t e d E B IT D A ( 1 ) JVs Performance Products & Solutions Distribution Specialty 7% 87% (2) Avient Corporation 12 T H E N E W A V I E N T : A S P E C I A L T Y G R O W T H C O M P A N Y     Transaction expected to add $0.85 to pro forma adjusted EPS Avient Corporation 13 SUSTAINABILITY AT AVIENT P E O P L E , P R O D U C T S , P L A N E T , P E R F O R M A N C E Avient Corporation 13 Avient Corporation 14 V I S I O N To be the world’s premier provider of specialized polymer materials, services and solutions C O R E V A L U E S P E R S O N A L V A L U E S Honesty IntegrityRespect Operational Excellence Commercial Excellence Specialization Globalization Collaboration ExcellenceInnovation To be the world’s premier provider of specialized polymer materials, services and sustainable solutions Avient Corporation 15 1.3 1.1 1.1 0.85 0.65 0.57 0.54 0.97 0.84 0.74 0.74 0.69 0.51 0.56 0.14 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 YTD S A F E T Y F I R S T Injuries per 100 Workers Spartech Acquisition Avient Corporation 16 G R E A T P L A C E T O W O R K Avient Corporation 17 C O M M O D I T Y T O S P E C I A L T Y T R A N S F O R M A T I O N • • • • • • • • • • • • 2006 - 2013 2013 – 20192000-2005 2006 - 2013 • • 2020 and Beyond Avient Corporation 18 A V I E N T 2 0 1 9 R E V E N U E | $ 2 . 9 B I L L I O N Segment End Market Geography Healthcare 15% Industrial 14% Consumer 14% Packaging 13% Transportation 13% Wire & Cable 11% Building & Construction 6% Electrical & Electronics 6% Textiles 5% Appliance 3% Color Additives & Inks 34% Distribution 41% Specialty Engineered Materials 25% United States 54% Europe 19% Asia 11% Latin America 11% Canada 5% Avient Corporation 19 Operating Income % of Sales 2006 2019 Color, Additives & Inks 1.7% 14.7% Specialty Engineered Materials 1.1% 11.6% Distribution 2.6% 6.3% 2009 2010 2011 2012 2013 2014 2015 2016* 2017* 2018 $2.43 P R O O F O F P E R F O R M A N C E C O N S E C U T I V E Y E A R S 1 0 $0.13 $0.68 $0.82 $1.00 $1.31 $1.80 $1.96 $2.06 $2.21 A D J U S T E D E P S E X P A N S I O N 2018 2019 $1.69 $1.51 Avient Corporation 20 531 710 1,032 130 164 207 504 663 871 2014 2018 Pro Forma R&D / Technical Marketing Sales + 34% + 26% + 32% E X P A N S I O N O F C O M M E R C I A L R E S O U R C E S D R I V I N G G R O W T H Revenue in Billions Total + 10% Organic + 7%+ 45% + 26% + 31% $4.0 $3.2 (2) (1) (1) $2.9 $2.9 $3.5 2015 2016 2017 2018 Pro Forma Total + 9% Organic + 5% Pro Forma(2) Avient Corporation 21 P R I O R A C Q U I S I T I O N S H I S T O R Y Commercial Resources(1) Operating Income ($ in millions) Operating Margins 256 350 At Acquisition 2019 $36 $100 At Acquisition 2019 9% 19% At Acquisition 2019 Established Acquisitions (> 7 years) + 37% + 176% + 1000 bps Avient Corporation 22 A L I G N I N G W I T H T R E N D S F O R G R O W T H T R A N S P O R T A T I O N P A C K A G I N G H E A L T H C A R E C O N S U M E R Facilitate alternative energy solutions Light- weighting Reduce packaging materials Improve recyclability Reduce spread of infection Avient Corporation 23 I N N O V A T I O N Customization 55% M&A 30% Innovation Pipeline 15% Innovation comes from Research & Development Spend Vitality Index 12% 37% 2006 2019 $20 $51 2006 2019 Avient Corporation 24 R E V E N U E F R O M S U S T A I N A B L E S O L U T I O N S $275M $325M $355M $410M 14% Total Annual Growth 9% Organic Annual Growth Avient Corporation 25 SEGMENT HIGHLIGHTS I N N O V A T I N G W I T H A V I E N T Avient Corporation 25 Avient Corporation 26 C O L O R , A D D I T I V E S & I N K S E N D M A R K E T S & S O L U T I O N S Solid Colorants Performance Additives Screen Printing Inks Liquid Colorants Packaging 31% Industrial 14% Textiles 13% Wire & Cable 10% Building & Construction 9% Consumer 8% Transportation 7% Healthcare 5% Appliances 2% Electrical & Electronics 1% Avient Corporation 26 Avient Corporation 27 Operating Income & MarginRevenue by Region C O L O R , A D D I T I V E S & I N K S 2 0 1 9 R E V E N U E | O V E R $ 1 B I L L I O N Europe 34% United States 44% Asia 15% Canada 1% Mexico 3% South America 3% $4 $25 $104 $147 2005 2009 2013 2019 0.9% 5.5% 12.2% 14.7% Avient Corporation 27 Avient Corporation 28 S P E C I A L T Y E N G I N E E R E D M A T E R I A L S E N D M A R K E T S & S O L U T I O N S Engineered Formulations Advanced Composites Thermoplastic Elastomers Wire & Cable* 28% Consumer 19% Electrical & Electronics 12% Healthcare 9% Industrial 8% Packaging 6% Appliance 2% Building & Construction 2% Transportation 14% Avient Corporation 28 Avient Corporation 29 S P E C I A L T Y E N G I N E E R E D M A T E R I A L S Revenue by Region Operating Income & Margin 2 0 1 9 R E V E N U E | $ 7 5 0 M I L L I O N Europe 27% United States 54% Asia 17% Canada 2% $21 $57 $87 2005 2009 2013 2019 0.1% 5.1% 9.3% 11.6% Avient Corporation 29 Avient Corporation 30 D I S T R I B U T I O N E N D M A R K E T S & S U P P L I E R S Healthcare 28% Industrial 19% Transportation 18% Consumer 17% Appliance 6% Electrical & Electronics 5% Building & Construction 4% Packaging 2% Wire & Cable 1% Operating Income & Margin2019 Revenue | $1.2 Billion $25 $63 $75 2005 2009 2013 2019 $20 2.9% 4.0% 5.9% 6.3% Avient Corporation 30 http://www.avient.com/Pages/VariationRoot.aspx Avient Corporation 31 O V E R V I E W O F R A W M A T E R I A L P U R C H A S E S Avient Corporation 31 Avient Corporation 32 Avient Corporation 33 Adjusted EPS attributable to PolyOne common shareholders is calculated as follows: 2009* 2010* 2011* 2012* 2013* 2014* 2015* 2016** 2017** 2018 2018*** Q1 2019*** 2019 Q1 2020 Net income from continuing operations attributable to PolyOne common shareholders Joint venture equity earnings, after tax Special items, before tax (1) Special items, tax adjustments (1) Adjusted net income from continuing operations attributable to PolyOne common shareholders $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 $ 166.4 $ 173.5 $ 161.1 $ 87.7 $ 22.4 $ 75.5 $ 33.1 (19.0) (14.7) (3.7) — — — — — — — — — — — (48.7) 24.2 (48.1) 55.1 46.3 164.2 87.6 23.8 32.9 59.5 58.7 12.2 61.7 9.6 (27.2) (96.7) (24.7) (18.9) (13.7) (73.7) (58.7) (15.9) (24.8) (25.3) (25.1) (1.2) (5.9) (1.0) $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 $ 174.3 $ 181.6 $ 195.3 $ 121.3 $ 33.4 $ 131.3 $ 41.7 Diluted shares 93.4 96.0 94.3 89.8 96.5 93.5 88.7 84.6 82.1 80.4 80.4 78.2 77.7 86.7 Adjusted EPS attributable to PolyOne common shareholders $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 $ 2.06 $ 2.21 $ 2.43 $ 1.51 $ 0.43 $ 1.69 $ 0.48 * Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principle, discontinued operations or the related resegmentation. ** Pro forma for sale of Designed Structures and Solutions segment (DSS). *** Pro forma for sale of Performance Products and Solutions segment (PP&S). Adjusted EPS attributable to Avient common shareholders is calculated as follows: 2009* 2010* 2011* 2012* 2013* 2014* 2015* 2016** 2017** 2018 2018*** 2019 Q2 2020 Net income from continuing operations attributable to Avient common shareholders $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 $ 166.4 $ 173.5 $ 161.1 $ 87.7 $ 75.5 $ 23.0 Joint venture equity earnings, after tax (19.0) (14.7) (3.7) — — — — — — — — — — Special items, before tax(1) (48.7) 24.2 (48.1) 55.1 46.3 164.2 87.6 23.8 32.9 59.5 58.7 61.7 2.4 Special items, tax adjustments(1) (27.2) (96.7) (24.7) (18.9) (13.7) (73.7) (58.7) (15.9) (24.8) (25.3) (25.1) (5.9) 0.2 Adjusted net income from continuing operations attributable to Avient common shareholders $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 $ 174.3 $ 181.6 $ 195.3 $ 121.3 $ 131.3 $ 25.6 Diluted shares 93.4 96.0 94.3 89.8 96.5 93.5 88.7 84.6 82.1 80.4 80.4 77.7 91.8 Adjusted EPS attributable to Avient common shareholders $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 $ 2.06 $ 2.21 $ 2.43 $ 1.51 $ 1.69 $ 0.28 * Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principle, discontinued operations or the related resegmentation. ** Pro forma for sale of Designed Structures and Solutions segment (DSS). *** Pro forma for sale of Performance Products and Solutions segment (PP&S). Reconciliation to Adjusted EPS Excluding Special Items and Impacts of February 2020 Equity Offering and May 2020 Debt Offering Three Months Ended June 30, 2020 Net income from continuing operations attributable to Avient common shareholders $ 23.0 Special items, after tax(1) 2.6 After tax interest expense, net arising from equity offering and debt offering proceeds 4.1 Adjusted net income excluding special items and impact of interest expense, net arising from equity offering and debt offering proceeds $ 29.7 Diluted weighted-average shares used to compute earnings per common share 91.8 Weighted-average impact of 15.3 million shares issued in February 2020 equity offering (15.3) Diluted weighted-average shares excluding impact of shares issued in February 2020 equity offering 76.5 Adjusted EPS excluding special items and impact of equity offering and debt offering $ 0.39 (1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures, including adjustments related to contingent consideration; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to-market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non- recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results.

CPE 30-33 ROHS BLACK 30

Copolyester, Polyester & PC/Polyester Blends Copolyester Eastman Tritan™ (Copolyester) High chemical resistance to a wide variety of hospital disinfectants; excellent toughness and impact resistance after disinfection; retains color and gloss after sterilization and disinfection; does not contain BPA, BPS or halogens Polybutylene Terephthalate (PBT) DuPont™ Crastin® & Rynite® (FR-PBT) 30% glass reinforced; flame retardant; good mold flow and electrical properties; high strength, stiffness, dimensional stability and heat resistance Polycarbonate/ Polyester (PC/PET) & Polycarbonate/ Polybutylene Terephthalate (PC/PBT) Covestro Makroblend® (FR-PC/PET) & (FR-PC/PBT) Strength; toughness; chemical resistance; flame retardant Covestro Makroblend® (Non-FR PC/PBT) Strength; toughness; chemical resistance; limited biocompatibility Trinseo EMERGE™ (FR-PC/PET) Chemical resistance; ignition resistance; limited biocompatibility PA, PVC, PC & PMMA Polyamide (Nylon, PA) Avient Trilliant™ XR Radiation Shielding (PA) Radiation shielding; green alternative for lead replacement; enhanced design freedom vs. lead; available in hard and soft durometers Arkema Rilsan® MED (PA11) & Rilsamid® MED (PA12) Chemical resistance; transparent and opaque; easy processing; creep resistance; temperature resistance; BPA-free; sterilizable by gamma, EtO and steam Polyvinyl Chloride (PVC) GEON Performance Solutions Resilience™ HC (PVC) Excellent chemical resistance; good strength and stiffness; very good surface quality; inherently flame resistant; available in all medical colors; excellent solvent bonding to PVC Polycarbonate (PC) Trinseo EMERGE™ (PC) Ignition resistant; transparent and opaque; glass-filled also available PolyMethyl Methacrylate (PMMA) Trinseo Plexiglas® Acrylics (PMMA) Clarity; easy processing; chemical resistance; BPA free; ideal for light piping and lenses Styrenics & FR-PC/ABS Blends Styrenics Trinseo MAGNUM™ (ABS) Opaque; custom colors; excellent impact and flow; low residuals; full biocompatibility INEOS Styrolution Terlux® HD (MABS) Good clarity; good heat and overall chemical resistance; good impact strength; good solvent bonding to PVC; outstanding surface quality INEOS Styrolution Lustran® & Novodur ® HD (ABS) Opaque appearance; outstanding chemical resistance; high impact strength; excellent balance of properties; ease of processability; bondable FR- Polycarbonate/ ABS (FR-PC/ABS) Covestro Bayblend® (FR-PC/ABS) Flame retardant; good impact resistance; dimensional stability; toughness Trinseo EMERGE™ (FR-PC/ABS) Ignition resistant; limited biocompatibility; high flow; easy processing; glass-filled also available RIGID COMPONENTS: DIAGNOSTIC, IMAGING, LIFE SUPPORT, LABORATORY, & MONITORING EQUIPMENT Applications include: • Housings • Covers • Monitor bezels • Body panels • Handles • Access panels • Battery enclosures • Wands • Coils Rigid Component Solution Needs: • Materials compliant with ISO 10993 & USP Class VI, if required • UL approved resins to meet flammability requirements • Housings with toughness & good impact resistance • Enclosures & components that withstand repeated cleanings • High-flow materials for components with complex designs FLEXIBLE COMPONENTS: DIAGNOSTIC, IMAGING, LIFE SUPPORT, LABORATORY, & MONITORING EQUIPMENT Applications include: • O-rings • Gaskets • Wheels • Soft touch grips/handles • Keypads/displays • Diaphragms • Seals Flexible Component Solution Needs: • Comfortable handles & grips • Water-tight seals • Durable feet or casters • Durable keypads • Flow control TPE, TPC-ET, TPU, TPV & Flexible PVC Thermoplastic Elastomers (TPE) Avient Versaflex™ HC Overmolding Series (TPE) Proven healthcare solutions with hardness ranges 42–65 Shore A; autoclave, radiation and EtO sterilizable; bondable to many substrates; customizable haptics Arkema Pebax® MED (TPE) Sterilizable by gamma and EtO; low energy return; soft touch; chemical resistance; overmolding material Thermoplastic Polyester Elastomers (TPC-ET) DuPont™ Hytrel® (TPC-ET) Wide range of flexibility, stiffness, and processing options; Shore D between 30-82; BPA-free; excellent flex fatigue and toughness; low temperature flexibility; good chemical resistance Thermoplastic Polyurethane (TPU) Covestro Texin® (TPU) Biocompatible; soft touch; sterilizable; good chemical resistance; overmold for grips and handles; excellent bonding to polar substrates like PC; 70A to 95A Thermoplastic Vulcanizate (TPV) Avient Versalloy™ (TPV) Proven healthcare solutions with hardness ranges 45–90 Shore A; autoclave, radiation and EtO sterilizable; natural and colorable; smooth texture; bonds to PP Exxon Mobil Santoprene™ (TPV) Durable sealing performance; elastic recovery; excellent chemical resistance; compliance with medical standards Flexible Polyvinyl Chloride (PVC) GEON Performance Solutions Geon™ Flexible PVC Engineered exclusively for the healthcare market; transparent and opaque colors; radiopaque grades available; durometer ranges from 55A to 40D; gamma and EtO sterilizable Thermoset Silicone Elastomers Thermoset Silicone Elastomers/ Liquid Silicone Rubber (LSR) DuPont™ Liveo™ Silicone Elastomers (LSR) Biocompatible; non-irritating and non-sensitization; sterilizable; made without plasticizers, phthalates or latex PVC Polyvinyl Chloride (PVC) GEON Performance Solutions Geon™ Flexible PVC Inherent flame resistance; halogen-free; excellent chemical resistance; non-yellowing; proven safety record in wire and cable applications; high temperature grades available TPE, TPC-ET, TPU & POE Thermoplastic Polyester (TPE) Arkema Pebax® (TPE) Flexibility; chemical resistance; easy processing; abrasion resistance; low coefficient of friction Thermoplastic Polyester Elastomers (TPC-ET) DuPont™ Hytrel® (TPC-ET) REACH, RoHS and WEEE compliant; wide range of flexibility, stiffness, and processing options; 30D-82D; BPA-free; excellent flex fatigue and toughness; low temperature flexibility; good chemical resistance Thermoplastic Polyurethane (TPU) Covestro Texin® (TPU) RoHs, WEEE, and REACH compliant; excellent memory and recoil; abrasion resistance; Texin® Rx Series - medical grade Polyether TPU – 70A to 80D Polyolefin Elastomer (POE) Avient ECCOH™ Non-halogenated flame retardant; high flexibility; environmental stress cracking resistance (ESCR); good electrical properties PA Polyamide (Nylon, PA) Arkema Rilsan® (PA) Chemical resistance; easy processing; abrasion resistance; low coefficient of friction; dimensional stability WIRE & CABLE: DIAGNOSTIC, IMAGING, LIFE SUPPORT, LABORATORY, & MONITORING EQUIPMENT Applications include: • Plug molding • Flexible jacket • Heater cable insulation • Flexible cords • Coil cords & cable Wire & Cable Component Solution Needs: • Materials compliant with UL, RoHS, REACH & WEEE, if needed • Materials with good chemical, moisture & abrasion resistance • Low smoke & non-halogen materials CUSTOM AVIENT SOLUTIONS FOR MEDICAL EQUIPMENT Custom Solution Needs Avient™ Custom Solutions Specialized materials to meet unique application requirements Avient Trilliant™ Healthcare products are a line of customized solutions specific for regulated medical devices; color branding expertise FDA-registered pre-colored resins and masterbatch options; color coding for safety and brand recognition Avient collaborates with key material suppliers to provide FDA-approved pre-colored resins Avient OnColor™ HC Plus offers customizable color masterbatch solutions pre-certified for biocompatibility using ISO 10993 and USP Class VI test protocol Reduced growth of microbes Avient WithStand™ additive technologies inhibit growth of microbes that often cause odor, staining and loss of mechanical properties AVIENT DISTRIBUTION Healthcare Supplier Line Card You face a unique set of challenges when designing parts for the healthcare industry.